Post-Market Drug Safety Forum

marcus evans invites you to attend our Post-Market Drug Safety Forum, geared towards Vice Presidents, Directors, and Managers involved in the biopharmaceutical industry. Hear from leading executives within the industry on how to develop innovative methods of signal detection and mitigating adverse events.

Attending this premier conference will give you the chance to address critical issues within the industry such as the changing global regulations, adverse event reporting in emerging markets, signal detection and establishing drug safety protocol. This conference recognizes that the pharmaceutical industry continually must find innovative ways to monitor and mitigate risk. By attending this conference, you will walk away with valuable knowledge on the FDA Sentinel Initiative, the Drug Safety and Accountability Act, and how to establish Risk Evaluations and Mitigation Strategies.

Attending this conference will allow you to:

·Discover innovative ways to identify adverse events in real time

·Enhance signaling methods to report and submit adverse events to regulatory bodies

·Understand Global pharmacovigilance and regulatory challenges in an effort to harmonize global safety strategy

·Review REMS Strategy and discuss the Drug Safety and Accountability Act to better understand new regulations

·Utilize specialty pharmacies to ensure proper patient and adverse event reporting structures

The marcus evans Post-Market Drug Safety Forum conference is a highly intensive, content-driven event that includes workshops, presentations, panel discussions, and roundtable discussions over three days. This conference invites senior level executives from leading (bio) pharmaceutical industry with involvement in pharmacovigilance, drug safety, drug safety risk management / REMS, medical safety, or regulatory affairs in order to provide an intimate atmosphere for both delegates and speakers.

For more information please contact:
Lindsey Silvetti
Email: Lindseysi@marcusevansch.com
Phone:(312) 540-3000 ext 6754